SCOTT GIBBS: Open Payments
NPI 1912959321 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,408 in 106 payments from 20 companies in 2025. Trend: 2023 $1,106 · 2024 $794 · 2025 $1,408
Food & beverage: $1,408
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $264 |
| PFIZER INC. | 18 | $204 |
| GlaxoSmithKline, LLC. | 22 | $164 |
| Novo Nordisk Inc | 10 | $146 |
| Lilly USA, LLC | 11 | $142 |
| Phathom Pharmaceuticals, Inc. | 11 | $86 |
| Edwards Lifesciences Corporation | 3 | $81 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Boston Scientific Corporation | 1 | $39 |
Products named: UBRELVY, TRELEGY ELLIPTA, NURTEC ODT, MOUNJARO, VOQUEZNA, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), PREVNAR 20, QULIPTA.
Industry payments across ID — which companies pay providers there.
